Researchers have discovered a potential therapeutic target in muscular disorders by identifying a previously unrecognized ...

For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne ...

The complexity of the TME in vivo limits the conclusions that can be drawn from in vivo models. Optimizing cell culture ...

For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne muscular dystrophy, aging or other degenerative conditions, muscle loss can ...

Cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in Non-Hispanic Black Patients, ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 decreased to approximately $2,044,000 ...

Molecular Partners AG’s MOLN share price has surged by 9.28%, which has investors questioning if this is right time to sell.

For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne muscular dystrophy, aging ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

Methods: To study accessibility and reproducibility in cardiovascular research reporting, we screened 639 randomly selected articles published in 2019 in three top cardiovascular science publications: ...